Docking to Simulation in 1 Click

No coding, no setup, no headache.

Request Early Access

SimAtomic Platform Interface

How SimAtomic Works

Easy, fast, instant results

Upload File

Drop your protein and ligand files

Docking

Choose between AI or traditional docking

Simulation

Run fast Molecular Dynamics simulations online

Demo Results

SimAtomic Workflow Example

SimAtomic Platform Features

Advanced molecular simulation tools - accessible through your browser

ML-Powered Docking

Advanced molecular docking with pre-trained AI models that accelerate ligand pose identification.

Fast MD Simulation

Molecular dynamics simulations that run on H100 GPUs providing 10x faster results for drug discovery.

Instant Visualization

Interactive 3D visualization and analysis tools that let you explore results immediately without additional software.

SimAtomic vs Traditional Approach

See how SimAtomic simplifies molecular simulation

Feature SimAtomic Platform Traditional Approach
Setup Time 1 minute Hours to days
Technical Expertise No coding required Programming & command line
Software Installation Browser-based Complex installations
AI Enhancement Choose between AI models Black box approach
Compute Resources Elastic GPU scaling Fixed hardware limits
Pricing Model Fixed subscription + pay per compute Expensive annual licenses
Cost Efficiency Pay only for resources used Pay whether you use it or not
Scalability Scale up/down instantly Limited by hardware

Additional Services

Need more than the platform offers? We also provide custom solutions

Custom AI & Software Development

Custom machine learning models and software solutions tailored to your specific drug discovery needs, including new feature development for your workflows.

On-Premise Implementation

Deploy SimAtomic's platform within your secure environment. We handle the complete setup and integration with your existing infrastructure.

Workshops & Consulting

Expert training and strategic guidance on integrating molecular simulation and AI into your drug discovery pipeline and research workflows.

About SimAtomic

Ingrid Barbosa-Farias

Ingrid Barbosa-Farias, CEO & Founder

SimAtomic was founded to address the critical computational bottlenecks facing pharmaceutical drug discovery. With extensive experience in small molecule drug discovery, AI and software development, our team bridges the gap between cutting-edge AI/ML technologies and practical drug discovery applications. Our team members have worked directly in stem cell research, high-throughput microfluidics, and DNA-encoded libraries, giving us deep insight into the computational challenges pharma companies face when integrating advanced tools into their pipelines.

SimAtomic combines academic rigor with industry practicality, supported by a network of experts in AI, molecular dynamics simulation, and pharmaceutical development. We deliver enterprise-grade solutions that integrate seamlessly into existing drug discovery workflows.